Published in Neurol Sci on September 25, 2010
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. PLoS One (2012) 1.04
Treatment of cognitive impairment in multiple sclerosis: position paper. J Neurol (2012) 1.04
Efficacy and side effects of natalizumab therapy in patients with multiple sclerosis. J Cent Nerv Syst Dis (2014) 0.87
Natalizumab efficacy on cognitive impairment in MS. Neurol Sci (2011) 0.86
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study. Health Qual Life Outcomes (2012) 0.86
Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosis. Front Neurol (2015) 0.79
Cognitive impairment in multiple sclerosis. Curr Neurol Neurosci Rep (2012) 0.78
Natalizumab Significantly Improves Cognitive Impairment over Three Years in MS: Pattern of Disability Progression and Preliminary MRI Findings. PLoS One (2015) 0.77
Long-term safety and efficacy of natalizumab in relapsing-remitting multiple sclerosis: impact on quality of life. Patient Relat Outcome Meas (2014) 0.77
Natalizumab discontinuation is associated with a rebound of cognitive impairment in multiple sclerosis patients. J Neurol (2016) 0.75
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol (1983) 26.67
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med (2006) 11.29
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature (1992) 7.20
Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills (1977) 6.58
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med (2006) 6.25
A simple objective technique for measuring flexibility in thinking. J Gen Psychol (1948) 4.00
Cognitive impairment in multiple sclerosis. Lancet Neurol (2008) 3.77
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study. Lancet Neurol (2009) 2.82
Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol (2007) 1.88
[Italian standardization and classification of Neuropsychological tests. The Italian Group on the Neuropsychological Study of Aging]. Ital J Neurol Sci (1987) 1.85
MRI outcomes in a placebo-controlled trial of natalizumab in relapsing MS. Neurology (2007) 1.56
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS. Expert Rev Neurother (2004) 1.40
Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol (2000) 1.39
Cognitive impairment in multiple sclerosis. Mult Scler (2008) 1.29
Cognitive impairment as marker of diffuse brain abnormalities in early relapsing remitting multiple sclerosis. J Neurol Neurosurg Psychiatry (2005) 1.09
Neuropsychologic status in multiple sclerosis after treatment with glatiramer. Arch Neurol (1999) 1.06
Improved delayed visual reproduction test performance in multiple sclerosis patients receiving interferon beta-1b. Neurology (1996) 0.94
Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option? CNS Drugs (2008) 0.94
Cognitive function in relapsing multiple sclerosis: minimal changes in a 10-year clinical trial. J Neurol Sci (2007) 0.90
Effect of interferon-beta-1b on cognitive functions in multiple sclerosis. Eur Neurol (2002) 0.83
Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year study. Isr Med Assoc J (2007) 0.78
Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci (2004) 1.92
Acute myeloid leukemia in Italian patients with multiple sclerosis treated with mitoxantrone. Neurology (2011) 1.68
A diffusion tensor MRI study of cervical cord damage in benign and secondary progressive multiple sclerosis patients. J Neurol Neurosurg Psychiatry (2009) 1.64
Comparison of GEANT4 very low energy cross section models with experimental data in water. Med Phys (2010) 1.35
Internal models in the control of posture. Neural Netw (1999) 1.31
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17
A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients. J Neurol Neurosurg Psychiatry (2003) 1.08
Cognitive impairment and structural brain damage in benign multiple sclerosis. Neurology (2008) 1.06
Myasthenic crisis during intravenous iodinated contrast medium injection. Ital J Neurol Sci (1986) 1.03
MRI and magnetization transfer imaging changes in the brain and cervical cord of patients with Devic's neuromyelitis optica. Neurology (1999) 0.98
Neuropsychological assessment in patients with relapsing-remitting multiple sclerosis and mild functional impairment: correlation with magnetic resonance imaging. J Neurol Neurosurg Psychiatry (1990) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
Brain involvement in systemic immune mediated diseases: magnetic resonance and magnetisation transfer imaging study. J Neurol Neurosurg Psychiatry (2000) 0.95
Neuropsychological rehabilitation in adult multiple sclerosis. Neurol Sci (2010) 0.93
Mitoxantrone for multiple sclerosis. Cochrane Database Syst Rev (2005) 0.93
Very low level laser therapy attenuates edema and pain in experimental models. Int J Tissue React (2004) 0.91
Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort. Eur J Neurol (2010) 0.89
Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI. Neurology (2006) 0.88
Frequency and risk factors of mitoxantrone-induced amenorrhea in multiple sclerosis: the FEMIMS study. Mult Scler (2008) 0.88
Fragment collapsing and splitting while assembling high-resolution restriction maps. J Comput Biol (1995) 0.87
Safety and efficacy of natalizumab in children with multiple sclerosis. Neurology (2010) 0.87
Natalizumab efficacy on cognitive impairment in MS. Neurol Sci (2011) 0.86
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. Neurol Sci (2013) 0.86
The effect of imprecise repositioning on lesion volume measurements in patients with multiple sclerosis. Neurology (1997) 0.85
In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Mult Scler (2009) 0.84
Interferon-beta therapy monitoring in multiple sclerosis patients. Endocr Metab Immune Disord Drug Targets (2009) 0.84
Early peripheral nerve abnormalities in impaired glucose tolerance. Electromyogr Clin Neurophysiol (2005) 0.83
Renewal of the T-cell compartment in multiple sclerosis patients treated with glatiramer acetate. Mult Scler (2009) 0.83
Interferon beta treatment for multiple sclerosis has a graduated effect on MRI enhancing lesions according to their size and pathology. J Neurol Neurosurg Psychiatry (1999) 0.83
Observation of a new Ds meson decaying to DK at a mass of 2.86 GeV/c2. Phys Rev Lett (2006) 0.82
Search for decays of B0-->e+ e-, B0-->mu+ mu-, B0-->e +/- mu-/+. Phys Rev Lett (2005) 0.81
Measurement of the B-->Xsl+l- branching fraction with a sum over exclusive modes. Phys Rev Lett (2004) 0.81
Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis. J Neurol Neurosurg Psychiatry (1996) 0.81
Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging. J Neurol (1991) 0.80
Disease activity in multiple sclerosis studied by weekly triple-dose magnetic resonance imaging. J Neurol (1999) 0.79
Moyamoya syndrome in only one of two identical twins. Case report. J Neurosurg (1983) 0.79
Serial study of neuropsychological performance and gadolinium-enhanced MRI in MS. Acta Neurol Scand (1993) 0.79
Serial gadolinium-DTPA of spinal cord MRI in multiple sclerosis: triple vs. single dose. Magn Reson Imaging (2000) 0.79
Intraobserver and interobserver variability in measuring changes in lesion volume on serial brain MR images in multiple sclerosis. AJNR Am J Neuroradiol (1998) 0.78
The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases. J Neurol (2000) 0.78
Elevated concentrations of plasma alpha-melanocyte stimulating hormone are associated with reduced disease progression in HIV-infected patients. J Lab Clin Med (1999) 0.78
Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group--Italian Neurological Society. Neurol Sci (2011) 0.78
Modulation of the central memory and Tr1-like regulatory T cells in multiple sclerosis patients responsive to interferon-beta therapy. Mult Scler (2011) 0.78
Cumulative effect of a weekly low dose of interferon beta 1a on standard and triple dose contrast-enhanced MRI from multiple sclerosis patients. J Neurol Sci (1999) 0.78
Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases. J Neurol Sci (2000) 0.78
Measurement of the branching fraction and photon energy moments of B-->Xs gamma and A(CP)(B --> X(s+d gamma)). Phys Rev Lett (2006) 0.77
A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium-DTPA for monitoring disease activity in primary progressive multiple sclerosis. J Neuroimaging (1998) 0.77
MR imaging assessment of brain and cervical cord damage in patients with neuroborreliosis. AJNR Am J Neuroradiol (2006) 0.77
Limited clinical significance of traditional and quantitative EEG in multiple sclerosis. Acta Neurol Belg (1994) 0.77
[Clinical usefulness of the reticulocyte hemoglobin equivalent in chronic hemodialysis patients]. Rev Fac Cien Med Univ Nac Cordoba (2011) 0.76
Motor evoked potentials and disability in secondary progressive multiple sclerosis. Can J Neurol Sci (1997) 0.76
Progranulin gene variability increases the risk for primary progressive multiple sclerosis in males. Genes Immun (2010) 0.76
Molecular scale track structure simulations in liquid water using the Geant4-DNA Monte-Carlo processes. Appl Radiat Isot (2010) 0.76
A new type of very low-power modulated laser: soft-tissue changes induced in osteoarthritic patients revealed by sonography. Int J Clin Pharmacol Res (2000) 0.75
Measurement of the pseudoscalar decay constant fDs using charm-tagged events in e+e- collisions at square root s=10.58 GeV. Phys Rev Lett (2007) 0.75
Observation of a broad structure in the pi+ pi- J/psi mass spectrum around 4.26 GeV/c2. Phys Rev Lett (2005) 0.75
Measurement of the Cabibbo-Kobayashi-Maskawa angle gamma in B+/--->D*K+/- decays with a Dalitz analysis of D-->K0(S)pi-pi+. Phys Rev Lett (2005) 0.75
Production and decay of xi(c)(0) at BABAR. Phys Rev Lett (2005) 0.75
Improved Measurement of the Cabibbo-Kobayashi-Maskawa angle alpha using B0(B) --> rho+rho- decays. Phys Rev Lett (2005) 0.75
Measurement of time-dependent CP asymmetries and the CP-odd fraction in the decay B0-->D*+D*-. Phys Rev Lett (2005) 0.75
Measurement of the spin of the omega(-) hyperon. Phys Rev Lett (2006) 0.75
Measurement of the B-->pi l nu branching fraction and determination of absolute value of V(ub) with tagged B mesons. Phys Rev Lett (2006) 0.75
Measurement of the CP asymmetry and branching fraction of B0-->rho0K0. Phys Rev Lett (2007) 0.75
Search for the rare decay B0-->tau+tau- at BABAR. Phys Rev Lett (2006) 0.75
Measurement of the branching fraction of Gamma(4S) --> B0B0. Phys Rev Lett (2005) 0.75
Branching fraction and CP asymmetries of B0-->K0(S)K0(S)K0(S). Phys Rev Lett (2005) 0.75
Measurement of branching fractions and mass spectra of B-->Kpipigamma. Phys Rev Lett (2007) 0.75
Observation of B0 meson decay to a 1 +/(1260)pi /+. Phys Rev Lett (2006) 0.75
Determinations of from inclusive semileptonic decays with reduced model dependence. Phys Rev Lett (2006) 0.75
Search for T, CP, and CPT violation in B0-B0 mixing with inclusive dilepton events. Phys Rev Lett (2006) 0.75
Observation of a Charmed Baryon Decaying to D;{0}p at a Mass Near 2.94 GeV/c;{2}. Phys Rev Lett (2007) 0.75
Quality in emergency departments: a study on 3,285,440 admissions. J Prev Med Hyg (2007) 0.75
[Factors regulating and modifying the pulmonary circulation]. Torace (1979) 0.75
[A case of spondylodiscitis in chronic polyarthritis]. Reumatismo (1971) 0.75
Search for lepton flavor violation in the decay tau+/--->e+/-gamma. Phys Rev Lett (2006) 0.75
Determination of |Vub| from measurements of the electron and neutrino momenta in inclusive semileptonic B decays. Phys Rev Lett (2005) 0.75
Search for lepton-flavor and lepton-number violation in the decay tau(-) -->l-(+)h+(-)h'(-). Phys Rev Lett (2005) 0.75
Evidence for B+ --> K0K+ and B0 --> K0K0, and measurement of the branching fraction and search for direct CP violation in B+ --> K0pi+. Phys Rev Lett (2005) 0.75
Observation of B-->eta'K* and evidence for B+-->eta'rho+. Phys Rev Lett (2007) 0.75
Observation of Upsilon(4S) decays to pi(+)pi(-)Upsilon(1S) and pi(+)pi(-)Upsilon(2S). Phys Rev Lett (2006) 0.75
General intellectual impairment in chronic right hemisphere damaged patients with anosognosia: a group study. Neuropsychol Rehabil (2012) 0.75
Measurements of branching fractions and Dalitz distributions for B0 --> D(*)+/-K0pi-/+ decays. Phys Rev Lett (2005) 0.75
Measurement of branching fractions and resonance contributions for B0 --> D0K+pi- and search for B0 --> D0K+pi- decays. Phys Rev Lett (2006) 0.75
Observation of decays B0-->Ds(*)+ pi- and B0-->Ds(*)- K+. Phys Rev Lett (2007) 0.75
Observation of e(+)e(-) annihilation into the C = +1 hadronic final states rho(0)rho(0) and phirho(0). Phys Rev Lett (2006) 0.75
Measurements of branching fractions, polarizations, and direct CP-violation asymmetries in B-->rhoK* and B-->f0(980)K* decays. Phys Rev Lett (2006) 0.75
Search for strange-pentaquark production in e+e- annihilation at sqrt[s] = 10.58 GeV. Phys Rev Lett (2005) 0.75
Measurement of branching fractions and charge asymmetries in B+ decays to eta pi+, eta K+, eta rho+, and eta' pi+, and search for B0 decays to eta K0 and eta omega. Phys Rev Lett (2005) 0.75
Measurements of branching fractions and time-dependent CP-violating asymmetries in B --> eta'K decays. Phys Rev Lett (2005) 0.75
Improved measurements of CP-violating asymmetry amplitudes in B0-->pi+pi- decays. Phys Rev Lett (2005) 0.75
Measurement of time-dependent CP asymmetries in B0-->D(*)+/-D+/- decays. Phys Rev Lett (2005) 0.75
[Our experience on the so-called "ragocytosis"]. Reumatismo (1969) 0.75
Evidence of a broad structure at an invariant mass of 4.32 GeV/c2 in the reaction e+e- --> pi+pi-psi(2S) measured at BABAR. Phys Rev Lett (2007) 0.75
Search for lepton flavor violation in the decay tau+/- --> mu+ gamma. Phys Rev Lett (2005) 0.75
High-resolution CT of the petrous bone: direct vs. Reformatted images. AJNR Am J Neuroradiol (1982) 0.75
Measurements of the absolute branching fractions of B+/- --> K+/-X(cc). Phys Rev Lett (2006) 0.75
Search for D0-D0 mixing and branching-ratio measurement in the decay D0-->K+ pi- pi0. Phys Rev Lett (2006) 0.75